Kits Eyecare Stock Performance
| KITS Stock | CAD 9.19 0.34 3.84% |
The company secures a Beta (Market Risk) of -0.0186, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Kits Eyecare are expected to decrease at a much lower rate. During the bear market, Kits Eyecare is likely to outperform the market. At this point, Kits Eyecare has a negative expected return of -0.24%. Please make sure to verify Kits Eyecare's skewness, accumulation distribution, and the relationship between the potential upside and kurtosis , to decide if Kits Eyecare performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Kits Eyecare has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Last Split Factor 3:2 | Last Split Date 2007-05-14 |
1 | Kits Eyecare Completes Secondary Share Offering - TipRanks | 09/26/2024 |
2 | Kits Eyecare Third Quarter 2024 Earnings EPS CA0.004 - Yahoo Finance | 11/08/2024 |
| Begin Period Cash Flow | 18.8 M |
Kits |
Kits Eyecare Relative Risk vs. Return Landscape
If you would invest 1,090 in Kits Eyecare on September 2, 2024 and sell it today you would lose (171.00) from holding Kits Eyecare or give up 15.69% of portfolio value over 90 days. Kits Eyecare is generating negative expected returns and assumes 2.4778% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than Kits, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Kits Eyecare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kits Eyecare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Kits Eyecare, and traders can use it to determine the average amount a Kits Eyecare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0949
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | KITS |
Estimated Market Risk
| 2.48 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Kits Eyecare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kits Eyecare by adding Kits Eyecare to a well-diversified portfolio.
Kits Eyecare Fundamentals Growth
Kits Stock prices reflect investors' perceptions of the future prospects and financial health of Kits Eyecare, and Kits Eyecare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kits Stock performance.
| Return On Equity | -0.002 | ||||
| Return On Asset | 0.0039 | ||||
| Profit Margin | (0.0007) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 283.99 M | ||||
| Shares Outstanding | 31.58 M | ||||
| Price To Book | 5.44 X | ||||
| Price To Sales | 1.99 X | ||||
| Revenue | 120.51 M | ||||
| Gross Profit | 29.25 M | ||||
| EBITDA | 2.34 M | ||||
| Net Income | (2.21 M) | ||||
| Cash And Equivalents | 18.79 M | ||||
| Cash Per Share | 0.60 X | ||||
| Total Debt | 15.39 M | ||||
| Debt To Equity | 0.40 % | ||||
| Current Ratio | 1.80 X | ||||
| Book Value Per Share | 1.69 X | ||||
| Cash Flow From Operations | 2.4 M | ||||
| Earnings Per Share | (0.01) X | ||||
| Market Capitalization | 290.19 M | ||||
| Total Asset | 87.64 M | ||||
| Retained Earnings | (27.91 M) | ||||
| Working Capital | 9.46 M | ||||
About Kits Eyecare Performance
By examining Kits Eyecare's fundamental ratios, stakeholders can obtain critical insights into Kits Eyecare's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Kits Eyecare is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 70.55 | 52.10 | |
| Return On Tangible Assets | (0.05) | (0.05) | |
| Return On Capital Employed | (0.04) | (0.04) | |
| Return On Assets | (0.03) | (0.03) | |
| Return On Equity | (0.04) | (0.04) |
Things to note about Kits Eyecare performance evaluation
Checking the ongoing alerts about Kits Eyecare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Kits Eyecare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Kits Eyecare generated a negative expected return over the last 90 days | |
| The company reported the revenue of 120.51 M. Net Loss for the year was (2.21 M) with profit before overhead, payroll, taxes, and interest of 29.25 M. | |
| About 76.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Kits Eyecare Third Quarter 2024 Earnings EPS CA0.004 - Yahoo Finance |
- Analyzing Kits Eyecare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kits Eyecare's stock is overvalued or undervalued compared to its peers.
- Examining Kits Eyecare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kits Eyecare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kits Eyecare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Kits Eyecare's stock. These opinions can provide insight into Kits Eyecare's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Kits Stock
Kits Eyecare financial ratios help investors to determine whether Kits Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kits with respect to the benefits of owning Kits Eyecare security.